DIN 02547473 — APRETUDE 200 MG
APRETUDE is a suspension (extended-release) of Cabotegravir marketed by VIIV HEALTHCARE ULC. The full Cabotegravir monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02547473
- Brand name
- APRETUDE
- Active ingredient
- Cabotegravir
- Strength
- 200 MG
- Dosage form
- SUSPENSION (EXTENDED-RELEASE)
- Route
- INTRAMUSCULAR
- Manufacturer
- VIIV HEALTHCARE ULC
- Health Canada status
- MARKETED
- Drug class
- HIV-1 integrase strand transfer inhibitor (INSTI) — antiretroviral agent for pre-exposure prophylaxis
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Cabotegravir products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02547465 | APRETUDE | 30 MG | TABLET | VIIV HEALTHCARE ULC | MARKETED |
| 02497204 | VOCABRIA | 30 MG | TABLET | VIIV HEALTHCARE ULC | MARKETED |